Professor | Xiaoping Zou | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Xiaoping Zou
Contact Information	zouxp@nju.edu.cn
Language ability	Chinese, English
Province	Jiangsu

Upload Avatar (500 x 500)

Name

Xiaoping Zou

Contact Information

zouxp@nju.edu.cn

Language ability

Chinese, English

Province

Jiangsu

University/Lab Affiliation and Title	Nanjing University
Faculty	Medical School
Awards	Shanghai Science and Technology Progress Award First Prize (2004): Research on Clinical Application of Upper Gastrointestinal Endoscopy National Science and Technology Progress Award Second Prize (2005): Research and Application of Minimally Invasive Techniques for Gastroscopy and Duodenoscopy Jiangsu Provincial Health Department Medical New Technology Introduction Award First Prize (2008): Endoscopic Submucosal Dissection Jiangsu Provincial Health Department Medical New Technology Introduction Award First Prize (2011): Clinical Application of Endoscopic Ultrasound-Guided Interventional Techniques for Pancreatic Diseases Jiangsu Medical Science and Technology Second Prize (2012): Clinical Application and Basic Research of Digestive Endoscopy Jiangsu Provincial Medical New Technology Introduction Award First Prize (2014): Cluster Strategy for Neoadjuvant Chemoradiotherapy Combined with Liver Transplantation for Unresectable Hilar Cholangiocarcinoma Jiangsu Provincial Science and Technology Award Second Prize (2017): Mechanism of PPI Reversing Tumor Acidic Microenvironment to Improve Malignant Biological Behavior of Gastric Cancer Jiangsu Medical Science and Technology First Prize (2018): Establishment and Application of Minimally Invasive Diagnosis and Treatment Platform for Digestive Diseases Chinese Medical Science and Technology Award Second Prize (2018): Establishment and Application of Minimally Invasive Diagnosis and Treatment Platform for Digestive Diseases Jiangsu Provincial Medical New Technology Introduction Award Second Prize (2020): Clinical Application of a Prognostic Scoring System for Gastric Cancer Based on 53 Gene Tags

University/Lab Affiliation and Title

Nanjing University

Faculty

Medical School

Awards

Shanghai Science and Technology Progress Award First Prize (2004): Research on Clinical Application of Upper Gastrointestinal Endoscopy
National Science and Technology Progress Award Second Prize (2005): Research and Application of Minimally Invasive Techniques for Gastroscopy and Duodenoscopy
Jiangsu Provincial Health Department Medical New Technology Introduction Award First Prize (2008): Endoscopic Submucosal Dissection
Jiangsu Provincial Health Department Medical New Technology Introduction Award First Prize (2011): Clinical Application of Endoscopic Ultrasound-Guided Interventional Techniques for Pancreatic Diseases
Jiangsu Medical Science and Technology Second Prize (2012): Clinical Application and Basic Research of Digestive Endoscopy
Jiangsu Provincial Medical New Technology Introduction Award First Prize (2014): Cluster Strategy for Neoadjuvant Chemoradiotherapy Combined with Liver Transplantation for Unresectable Hilar Cholangiocarcinoma
Jiangsu Provincial Science and Technology Award Second Prize (2017): Mechanism of PPI Reversing Tumor Acidic Microenvironment to Improve Malignant Biological Behavior of Gastric Cancer
Jiangsu Medical Science and Technology First Prize (2018): Establishment and Application of Minimally Invasive Diagnosis and Treatment Platform for Digestive Diseases
Chinese Medical Science and Technology Award Second Prize (2018): Establishment and Application of Minimally Invasive Diagnosis and Treatment Platform for Digestive Diseases
Jiangsu Provincial Medical New Technology Introduction Award Second Prize (2020): Clinical Application of a Prognostic Scoring System for Gastric Cancer Based on 53 Gene Tags

Areas of Focus	Gastric Cancer Pancreatic Cancer
Publications	BET protein inhibitor JQ1 downregulates chromatin accessibility and suppresses metastasis of gastric cancer via inactivating RUNX2/NID1 signaling., Oncogenesis, 2020 Development and validation of a real-time artificial intelligence-assisted system for detecting early gastric cancer: A multicentre retrospective diagnostic study., EBioMedicine, 2020 ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose Metabolism., Frontiers in Oncology, 2020 m6A Reader HNRNPA2B1 Promotes Esophageal Cancer Progression via Up-Regulation of ACLY and ACC1., Frontiers in Oncology, 2020 METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance., Gut, 2020 Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma., American Journal of Cancer Research, 2019 Proton pump inhibitor pantoprazole inhibits gastric cancer metastasis via suppression of telomerase reverse transcriptase gene expression., Cancer Letters, 2019 CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263., Cell Death and Disease, 2019 SIRT1 inhibits gastric cancer proliferation and metastasis via STAT3/MMP-13 signaling., Journal of Cellular Physiology, 2019 The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming., Neoplasia, 2019

Areas of Focus

Gastric Cancer
Pancreatic Cancer

Publications

BET protein inhibitor JQ1 downregulates chromatin accessibility and suppresses metastasis of gastric cancer via inactivating RUNX2/NID1 signaling., Oncogenesis, 2020
Development and validation of a real-time artificial intelligence-assisted system for detecting early gastric cancer: A multicentre retrospective diagnostic study., EBioMedicine, 2020
ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose Metabolism., Frontiers in Oncology, 2020
m6A Reader HNRNPA2B1 Promotes Esophageal Cancer Progression via Up-Regulation of ACLY and ACC1., Frontiers in Oncology, 2020
METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance., Gut, 2020
Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma., American Journal of Cancer Research, 2019
Proton pump inhibitor pantoprazole inhibits gastric cancer metastasis via suppression of telomerase reverse transcriptase gene expression., Cancer Letters, 2019
CDK7 inhibitor THZ1 inhibits MCL1 synthesis and drives cholangiocarcinoma apoptosis in combination with BCL2/BCL-XL inhibitor ABT-263., Cell Death and Disease, 2019
SIRT1 inhibits gastric cancer proliferation and metastasis via STAT3/MMP-13 signaling., Journal of Cellular Physiology, 2019
The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming., Neoplasia, 2019

Gastric Cancer Pancreatic Cancer Mechanism Endoscopy Diagnosis Intervention Ultrasound Ercp Research Treatment

Liwei Cao - Southern University of Science and Technology

Yang Fu - Southern University of Science and Technology

Zhuo Wang - Southern University of Science and Technology

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us